RBC Capital analyst Deane Dray maintains Flowserve (NYSE:FLS) with a Sector Perform and raises the price target from $26 to $30.
Raymond James Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $120
Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $124 to $120.